We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+34.85%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
–
Cap. Flow
+$115M
Cap. Flow %
93.08%
Top 10 Hldgs %
67.23%
Holding
58
New
58
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KRYS icon
Krystal Biotech
KRYS
+$12.7M
2
CVX icon
Chevron
CVX
+$12M
3
XOM icon
ExxonMobil
XOM
+$9.57M
4
TGTX icon
TG Therapeutics
TGTX
+$8.78M
5
VKTX icon
Viking Therapeutics
VKTX
+$7.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 60.01%
2 Energy 21.39%
3 Consumer Discretionary 4.59%
4 Technology 2.59%
5 Financials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTC
51
Grayscale Bitcoin Mini Trust ETF
BTC
$3.33B
$69.7K 0.06%
+1,800
New +$79.8K
CAPR icon
52
Capricor Therapeutics
CAPR
$223M
$43.3K 0.04%
+1,500
New +$19.6K
NVNO
53
enVVeno Medical
NVNO
$7.08M
$36.9K 0.03%
+3,286
New +$63.8K
YALA
54
Yalla Group
YALA
$818M
$34.7K 0.03%
+5,000
New +$35.8K
PDSB icon
55
PDS Biotechnology
PDSB
$38.4M
$23.1K 0.02%
+30,000
New +$27.1K
MLTX icon
56
MoonLake Immunotherapeutics
MLTX
$1.57B
$19.8K 0.02%
+1,500
New +$17.7K
1 2
3

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for ACT Capital Management, which disclosed 58 positions worth $124M. Its ten largest holdings account for 67% of the portfolio.

Its largest position is Krystal Biotech: 60,500 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, followed by Energy and Consumer Discretionary.

  • ACT Capital Management's largest Q4 2025 buy was Krystal Biotech: 60,500 shares worth $14.9M.
  • ACT Capital Management's ten largest holdings make up 67% of its $124M portfolio in Q4 2025.
  • ACT Capital Management disclosed 58 positions in Q4 2025, its first 13F filing on record.

Based on ACT Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.